Evidence map›Paper›PMID 27338614›Full record

ArticleBMC genomics2016

Cryptosporidium as a testbed for single cell genome characterization of unicellular eukaryotes.

Karin Troell, Björn Hallström, Anna-Maria Divne, Cecilia Alsmark, Romanico Arrighi, Mikael Huss, Jessica Beser, Stefan Bertilsson

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 59 citations in OpenAlex.

  1. Advancing genomics for waterborne pathogen surveillance in Australia.The Lancet regional health. Western Pacific · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Comparative genomics ofGenome research · 2024
    Article
  8. Article
  9. Current tropical medicine reports · 2024
    Review
  10. Review
  11. InvestigatingInternational journal of molecular sciences · 2023
    Review
  12. Hastening Progress inMicroorganisms · 2022
    Article
  13. An update onJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Review
  14. The Long and Short of Next Generation Sequencing forFrontiers in cellular and infection microbiology · 2022
    Review
  15. Article
  16. Article
  17. Review
  18. Challenges forGenes · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Karin TroellDepartment of Microbiology, National Veterinary Institute, Uppsala, Sweden. karin.troell@sva.se.
Björn HallströmDepartment of Microbiology, Public Health Agency of Sweden, Solna, Sweden.
Anna-Maria DivneMicrobial Single Cell Genomics Facility, Department of Cell and Molecular Biology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Cecilia AlsmarkDepartment of Microbiology, National Veterinary Institute, Uppsala, Sweden.
Romanico ArrighiDepartment of Microbiology, Public Health Agency of Sweden, Solna, Sweden.
Mikael HussDepartment of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm University, Solna, Sweden.
Jessica BeserDepartment of Microbiology, Public Health Agency of Sweden, Solna, Sweden.
Stefan BertilssonDepartment of Ecology and Genetics, Limnology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden. stebe@ebc.uu.se.
Public Health Agency of Sweden · SESwedish Veterinary Agency · SEScience for Life Laboratory · SEStockholm University · SEUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfectious disease involving multiple genetically distinct populations of pathogens is frequently concurrent, but difficult to detect or describe with current routine methodology. Cryptosporidium sp. is a widespread gastrointestinal protozoan of global significance in both animals and humans. It cannot be easily maintained in culture and infections of multiple strains have been reported. To explore the potential use of single cell genomics methodology for revealing genome-level variation in clinical samples from Cryptosporidium-infected hosts, we sorted individual oocysts for subsequent genome amplification and full-genome sequencing.

resultsCells were identified with fluorescent antibodies with an 80 % success rate for the entire single cell genomics workflow, demonstrating that the methodology can be applied directly to purified fecal samples. Ten amplified genomes from sorted single cells were selected for genome sequencing and compared both to the original population and a reference genome in order to evaluate the accuracy and performance of the method. Single cell genome coverage was on average 81 % even with a moderate sequencing effort and by combining the 10 single cell genomes, the full genome was accounted for. By a comparison to the original sample, biological variation could be distinguished and separated from noise introduced in the amplification.

conclusionsAs a proof of principle, we have demonstrated the power of applying single cell genomics to dissect infectious disease caused by closely related parasite species or subtypes. The workflow can easily be expanded and adapted to target other protozoans, and potential applications include mapping genome-encoded traits, virulence, pathogenicity, host specificity and resistance at the level of cells as truly meaningful biological units.

Indexed as

GenomeGenomicsAllelesCryptosporidiumEukaryotaGenetic VariationGenotypeHigh-Throughput Nucleotide SequencingMutationOocystsPolymorphism, Single NucleotideApicomplexaCryptosporidiumFACSMultiple infectionSingle cell genomicsWhole genome amplification

Identifiers

PMID27338614
PMCPMC4917956
OpenAlexW2468735503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.